Multiple sclerosis (MS) remains one of the most challenging neurological conditions affecting millions worldwide. As pharmaceutical innovations accelerate and healthcare infrastructure improves, regional markets are experiencing significant transformation in treatment accessibility and therapeutic options. North American Leadership The US Multiple Sclerosis Market continues...